Competitive Technologies, Inc.
Company licenses additional patent to Melanotan Corp., gets shares of Epitan
Published in Law and Health Weekly, August 27th, 2005
Privately held MCI is the exclusive licensee for the portfolio of CTT-patented melanogenesis-inducing technologies. MCI has sublicensed CTT's portfolio to Epitan, Ltd., (EPT), an Australian company performing clinical trials on the technology. CTT and its clients will receive royalties on any sales of products associated with this additional patent. Terms of the agreement were not disclosed.
Melanogenesis is a biochemical process that stimulates the production of eumelanin, the dark pigment of the skin which is known to protect...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
More Articles from Law and Health Weekly
- CryoLife, Inc.
Biomaterials company to settle shareholder suits - DNAPrint genomics, Inc.
Genomics company launches new corporate marketing and product branding campaign - Healthcare Coverage
Elderplan expands into the Bronx - Imperial College London
EIAV-based lentiviral vectors efficient for corneal transduction - InkSure Technologies Inc.
InkSure signs contract for protection of ethical pharmaceuticals - Kroger Co.
Grocery chain, CMS launch program to help give seniors access to drug benefits - More from this issue of Law and Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
